Objective: a bioactivity assay method was established to enhance the quality control of Muscular Amino Acids and Peptides and Nucleosides for Injection.
目的：采用生物活性测定法加强控制注射用肌氨肽苷的质量。
The bioactivity of hIL-28A was determined in a virus protection assay.
hIL - 28a的生物活性是通过病毒保护试验确定的。
The bioactivity of recombinant hIL-29 was determined in a virus protection assay.
hIL - 29的生物活性是通过病毒保护试验确定的。
The bioactivity of recombinant mHis6IL-27 was determined in a virus protection assay.
重组蛋白mhis6il - 27的生物活性是通过病毒保护实验确定的。
SDS-PAGE was used to detect the purity of target protein. A higher bioactivity of purified products was shown by the determination of dot-blotting assay and fibrinogen-clotting analysis.
通过SDS - PAGE检测融合蛋白的纯度，采用点杂交和纤维蛋白凝结活性检测分析，显示纯化产物具有较高生物活性。
The bioactivity of granulysin fusion protein was measured by MTT assay.
MTT检测颗粒溶素融合蛋白的生物活性。
The bioactivity of granulysin fusion protein was measured by MTT assay.
MTT检测颗粒溶素融合蛋白的生物活性。
应用推荐